Phospholipid-Curcumin Complexes for Osteoarticular Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis, rheumatoid arthritis, and psoriatic arthritis, particularly osteoarthritis, lack effective pain reduction and are poorly tolerated by patients, with existing anti-inflammatory drugs causing significant side effects, and curcumin's low bioavailability hinders its therapeutic potential.
Innovation Solution
Compositions combining an extract of Curcuma longa, phospholipid-complexed curcumin, a lipophilic extract of Zingiber officinale, and isobutylamides of polyunsaturated fatty acids from plants like Echinacea spp., Zanthoxylum spp., and Acmella oleracea, which are synergistically effective in reducing inflammation and pain, especially osteoarticular pain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If curcumin is used to treat inflammation and pain, then anti-inflammatory activity is improved, but bioavailability is poor due to instability at physiological pH
Solution Approach 1:
The patent uses phospholipids as intermediary substances to form stable complexes with curcumin. These phospholipid-curcumin complexes act as mediators that protect curcumin from degradation at physiological pH while facilitating its absorption and transport in the body, thereby resolving the contradiction between maintaining anti-inflammatory activity and improving bioavailability.
Solution Approach 2:
The patent creates composite materials by combining curcumin with phospholipids to form stable complexes. This composite approach allows the system to simultaneously exhibit the anti-inflammatory properties of curcumin and the stability/bioavailability benefits of phospholipids, resolving the contradiction between therapeutic activity and bioavailability.
2Reliability
If NSAIDs are used to treat inflammation and pain, then pain reduction is achieved, but side effects increase especially at gastric and cardiac levels
Solution Approach 1:
The patent employs natural plant extracts with transient anti-inflammatory actions that do not accumulate in the body like NSAIDs. These natural compounds provide short-term pain relief without the cumulative toxic effects on gastric and cardiac systems, resolving the contradiction between efficacy and side effects.
Solution Approach 2:
The patent changes the chemical parameters from synthetic NSAIDs to natural plant-derived compounds with different mechanisms of action. This parameter change allows achieving pain reduction through natural anti-inflammatory pathways that do not cause the gastric and cardiac side effects associated with conventional NSAIDs.
3Object-generated harmful factors
If plant-based supplements are used for osteoarthritis treatment, then tolerability is improved, but pain reduction level remains poor
Solution Approach 1:
The patent merges multiple plant-based extracts (Curcuma longa, Zingiber officinale, Echinacea spp., Zanthoxylum spp., Acmella oleracea) into a synergistic combination. This merging allows the composition to maintain the high tolerability of individual plant extracts while achieving enhanced pain reduction efficacy through synergistic interactions between the different active compounds.
Solution Approach 2:
The patent creates a composite formulation combining multiple plant extracts with complementary mechanisms of action. This composite approach allows the system to achieve both high tolerability (inherent in all plant extracts) and improved pain reduction efficacy (through synergistic combination effects).
Data Source
AI summary
Disclosed are compositions comprising: a) an extract of Curcuma longa, curcumin or phospholipid-complexed curcumin; b) a lipophilic extract of Zingiber officinale; and c) a lipophilic extract obtained from plants containing isobutylamides of polyunsaturated fatty acids selected from the group consisting of Echinacea spp. extract, Zanthoxylum spp. extract and Acmella oleracea (Spilanthes oleracea) extract.